NSE filing, NSE: SHEEL. Summary written from the filing by ALFA Finder's alert engine.
Sheel Biotech Ltd: key numbers
- Share price
- ₹58.70
- Market cap
- ₹119.5 Cr
- Revenue (annual)
- ₹110.0 Cr
- Net profit (annual)
- ₹11.76 Cr
- P/E (TTM)
- 10.2×Sector 43.1×
- Promoter holding
- 72.31%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sheel Biotech Ltd
All →Sheel Biotech Other Announcement
Sheel Biotech Limited has clarified that the Corporate Governance Report is not applicable to the company as it is listed on the SME platform.
Sheel Biotech Bags ₹4.54 Cr Order from Department of Agriculture, Government of Himachal Pradesh
Sheel Biotech won a Rs.4.54 Crore award from Himachal Pradesh's Agriculture Department. The project establishes a blueberry farm and tissue culture laboratory.
- Value
- ₹4.54 Cr
- From
- Department of Agriculture, Government of Himachal Pradesh
Sheel Biotech Legal & Regulatory
SEBI issued an advisory letter to Sheel Biotech Limited for delayed disclosure of a monitoring agency report. No monetary penalty or restrictions were imposed on the company.
Sheel Biotech Annual General Meeting
Sheel Biotech Limited held its 35th Annual General Meeting on September 24, 2026. The meeting covered adoption of financial statements and approval of other ordinary resolutions.
Sheel Biotech Other Announcement
Sheel Biotech intimated that its Statutory Auditor Shyam Sunder Mangla & Co LLP has changed its name to S S Mangla & Co LLP effective 18 December 2025. No change in the auditor appointment itself.
Sheel Biotech Bags ₹14.53 Cr Order
Sheel Biotech Limited has finalised a commercial transaction for its Blueberry project, valued at ₹14.53 Crore. This contract marks a significant business development for the company.
- Value
- ₹14.53 Cr
Other other announcement announcements
All →Refractory Shapes Other Announcement
Refractory Shapes Ltd filed its Integrated Governance filing for the quarter and half year ended 30 Sep 2026. It claims exemption from the Corporate Governance Report and reported zero investor grievances.
Mahindra & Mahindra Financial Services Other Announcement
Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.
ACME Solar Holdings Other Announcement
ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.
eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.